Iran Specialty Board - Urology study materials
Iran Specialty Board - Urology study resources

Febrile Obstructing Proximal Ureteral Stone with Sepsis and Limited Access

Iran Specialty Board - Urology · Put your knowledge to work in context.

All case studies

Febrile Obstructing Proximal Ureteral Stone with Sepsis and Limited Access

A 56-year-old man with type 2 diabetes and a history of aspirin use presents with 2 days of fever, rigors, and left flank pain. Temperature is 38.9°C, heart rate 118/min, blood pressure 95/60 mmHg, and respiratory rate 24/min. White blood cell count is 19,000/µL, creatinine is 2.3 mg/dL (baseline 1.1), and lactate is 3.2 mmol/L. CT shows a 9-mm left proximal ureteral stone, moderate hydronephrosis, and perinephric stranding; there is no abscess. Urinalysis has more than 100 white cells per high-power field and positive nitrite. The emergency department has no interventional radiology until morning, but the urology resident can place a ureteral stent. The patient is started on ceftriaxone and fluids. He is alert but anxious and asks why the stone cannot be removed tonight.

1. What is the immediate management priority, and how would you choose between ureteral stent and percutaneous nephrostomy in this patient?

Read the worked answer

The immediate priority is source control of an obstructed, infected kidney in a patient with sepsis, not stone clearance. He needs simultaneous resuscitation-fluids, cultures, broad antibiotics, and monitoring-and urgent decompression. A 9-mm proximal stone with fever, hypotension, and lactate 3.2 mmol/L is a urologic emergency; delaying drainage for a stone procedure would increase the risk of septic shock and death.

The choice between stent and nephrostomy depends on anatomy, stone size, infection severity, and available expertise. A stent can be placed retrograde under local anesthesia or sedation and avoids an external tube, but it may fail if the stone is impacted, the ureter is narrow, or the bladder is difficult to access. A percutaneous nephrostomy is generally more reliable in severe sepsis with a large proximal stone and purulent urine, and it allows better drainage if the ureter is obstructed. Because interventional radiology is unavailable until morning, I would have the resident attempt a stent with a low threshold to convert to an emergent percutaneous nephrostomy or transfer if stent placement fails or the patient deteriorates. I would not perform ureteroscopy in this setting.

2. How would you select and adjust antibiotics, and what cultures are essential before starting?

Read the worked answer

I would obtain blood cultures and a urine culture before antibiotics whenever this does not delay treatment; in a septic patient, antibiotics should not be postponed for culture collection. Empiric coverage should target gram-negative Enterobacterales and account for this patient's diabetes, prior healthcare exposure, and local resistance patterns. Ceftriaxone is a reasonable start only if local extended-spectrum beta-lactamase rates are low; in a severely ill patient with risk factors, I would consider piperacillin-tazobactam or a carbapenem, with vancomycin added only if gram-positive risk is present. Renal dosing matters because his creatinine is 2.3 mg/dL.

After cultures return, I would narrow coverage and treat the identified organism for an appropriate duration, usually about 7–10 days after adequate drainage in complicated pyelonephritis, with longer courses if bacteremia or slow improvement. I would reassess daily for fever, hemodynamics, and renal function. The key reasoning is that antibiotics alone cannot sterilize an obstructed infected system; drainage and antimicrobial therapy must be paired.

3. After recovery, what is the definitive treatment plan and timing for the 9-mm stone, and why not proceed with ureteroscopy at the initial admission?

Read the worked answer

After the sepsis resolves and the patient is clinically stable, I would plan definitive stone treatment, usually within 2–4 weeks while the stent or nephrostomy remains in place. For a 9-mm proximal ureteral stone, ureteroscopy with laser lithotripsy is highly effective, but shockwave lithotripsy is also an option depending on stone density and local expertise. I would obtain a noncontrast CT to plan the approach and discuss stone clearance, stent duration, and the need for metabolic evaluation after clearance.

I would not perform ureteroscopy during the acute septic admission because instrumentation of an infected, obstructed system can precipitate bacteremia, ureteral injury, and worsening sepsis. The correct sequence is decompression and antibiotics first, then definitive stone surgery once infection is controlled. If the stent is not draining or the patient remains septic, I would escalate to percutaneous drainage rather than proceed to retrograde stone treatment.